Polymer-based excipients, including lactide-glycolide and lactic acid-glycolic acid polymers (PLGs and PLGAs, collectively referred to as LG polymers), play a vital role in enhancing controlled drug release, delivery and bioavailability—particularly in long-acting injectable (LAI) formulations. While these excipients offer multiple benefits, the industry faces challenges in excipient selection due to naming differences, formulation complexity, and raw material variability.

Join this webinar as USP experts take a deep dive into standards and solutions that support quality and performance across the drug lifecycle and present: 

• USP’s integrated framework to LG polymer excipient naming and characterization 
• Review of USP offerings for LG polymer USP standards, including monographs, general chapters, stimuli articles, and reference standards 
• Overview of USP’s emerging solutions, including analytical reference materials (ARMs), case studies, education courses, technical notes, and peer-reviewed journal articles 

By showcasing this integrated strategy, USP aims to empower stakeholders with these standards and solutions to navigate the complexities of excipient naming, selection and characterization for LAIs. 

Speakers:

• Dr. Peng Zhang – Principal Scientist, Science-Excipients, USP
• Dr. Sampada (Sam) Kharade, PhD, MS – Senior Industry Program Manager, Excipients and Food Ingredients, USP